Suboptimal primary cytoreductive surgery (residual disease ≥1 cm) or unresectable at pres...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-OVARIAN-SUBOPTIMAL-DEBULKING |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-26 | pending_clinical_signoff |
| Diseases | DIS-OVARIAN |
| Sources | SRC-ESMO-OVARIAN-2024 SRC-NCCN-OVARIAN-2025 |
Red Flag Origin
| Definition | Suboptimal primary cytoreductive surgery (residual disease ≥1 cm) or unresectable at presentation in advanced (FIGO III-IV) ovarian carcinoma. MDT-trigger for neoadjuvant chemo (NACT) → interval debulking surgery (IDS) pathway per CHORUS / EORTC55971 trials, rather than primary debulking. |
|---|---|
| Clinical direction | investigate |
| Category | organ-dysfunction |
Trigger Logic
{
"any_of": [
{
"comparator": ">=",
"finding": "primary_debulking_residual_cm",
"threshold": 1
},
{
"finding": "primary_debulking_unsuccessful",
"value": true
},
{
"finding": "fagotti_score_high_unresectable",
"value": true
}
],
"type": "composite_score"
}
Notes
Surgical-vs-NACT timing decision is the central MDT debate in advanced ovarian. Fagotti laparoscopic score predicts complete resection feasibility. Complete (R0) cytoreduction substantially improves PFS/OS — when achievable, primary debulking preferred. When R0 not achievable or patient frail/comorbid → NACT carbo+pacli × 3-4 cycles → IDS → 3 more cycles + maintenance.
Used By
Algorithms
ALGO-OVARIAN-ADVANCED-1L- ALGO-OVARIAN-ADVANCED-1L
Indications
IND-OVARIAN-ADVANCED-1L-CARBO-PACLI-HRD-NEG- IND-OVARIAN-ADVANCED-1L-CARBO-PACLI-HRD-NEGIND-OVARIAN-ADVANCED-1L-CARBO-PACLI-HRD-OLAP- IND-OVARIAN-ADVANCED-1L-CARBO-PACLI-HRD-OLAP